A hidden strategy: How SARS-CoV-2 uses fibrinogen to evade the immune system
As scientists, we often think we understand a virus—its structure, its tricks, the way it moves through the body. But every ...
SARS-CoV-2 Virus Is Still Circulating! Experts Warn – Here’s How To Boost Your Immunity To Stay Safe
Covid-19 is still circulating, though it's weaker now. Experts say it’s not a major threat but advise maintaining strong ...
AI learns to 'speak' genetic 'dialect' for future SARS-CoV-2 mutation prediction
It's been five years since COVID-19 was declared a global pandemic. As SARS-CoV-2 shifts to endemic status, questions about ...
A deadly, global pandemic hit five years ago; are we prepared for the next one?
This month marks five years since the COVID-19 pandemic began. The SARS-CoV-2 virus was circulating for months, likely ...
Pulmonology Advisor1d
COVID And The Eye: What We’ve Learned 5 Years Since The Start of The Pandemic
Five years from the start of the COVID-19 pandemic, numerous academic studies have shown how the novel coronavirus affects ocular health.
Medscape2d
No Rise in T2D Risk After Mild COVID-19 in Vaccinated Adults
No increased risk for new-onset T2D was found after mild SARS-CoV-2 infection in a multiethnic Asian cohort during the ...
Science Daily22h
An antiviral chewing gum to reduce influenza and herpes simplex virus transmission
Low vaccination rates for influenza viruses and the lack of an HSV vaccine underscore the need for a new approach to reduce viral transmission. Researchers have now used a clinical-grade antiviral ...
Scientific American8d
COVID Research Funding to Be Slashed, NIH Documents Show
Studies on COVID, climate change and South Africa are on the latest list of terminated grants by the U.S. National Institutes ...
Queens Chronicle2d
First they called it ‘the novel coronavirus’
The first mention of Covid-19 in the Queens Chronicle came on Jan. 30, 2020, in a story headlined “Coronavirus fears seep ...
Physician's Weekly1d
Molnupiravir Impact on Viral Clearance and Treatment Duration
The following is a summary of “A viro-immunological model to characterize the antiviral effect of molnupiravir in SARS-CoV-2-infected outpatients: implication for treatment duration,” published in the ...